Artrya Limited (ASX:AYA)

Market Cap	332.60M
Revenue (ttm)	28.00K
Net Income (ttm)	-16.41M
Shares Out	147.82M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	359,973
Average Volume	799,773
Open	2.230
Previous Close	2.300
Day's Range	2.170 - 2.300
52-Week Range	0.250 - 2.450
Beta	0.59
RSI	59.76
Earnings Date	Nov 23, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AYA